Case Reports
doi: 10.1016/j.gcb.2010.01.016.
Epub 2010 Feb 26.
Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab
- PMID: 20189334
- DOI: 10.1016/j.gcb.2010.01.016
Item in Clipboard
Case Reports
Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab
Gastroenterol Clin Biol.
2010 Sep.
Free article
No abstract available
Similar articles
-
Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.BioDrugs. 2010 Dec 14;24 Suppl 1:25-7. doi: 10.2165/11586210-000000000-00000. BioDrugs. 2010. PMID: 21175232
-
Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.J Crohns Colitis. 2011 Apr;5(2):157-61. doi: 10.1016/j.crohns.2010.11.001. Epub 2010 Dec 7. J Crohns Colitis. 2011. PMID: 21453886
-
[Adalimumab in Crohn's disease - data from real life].Rev Esp Enferm Dig. 2008 Nov;100(11):671-5. doi: 10.4321/s1130-01082008001100001. Rev Esp Enferm Dig. 2008. PMID: 19159169 Spanish. No abstract available.
-
How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease.Rev Gastroenterol Disord. 2004;4 Suppl 3:S25-33. Rev Gastroenterol Disord. 2004. PMID: 15583528 Review.
-
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. BioDrugs. 2010. PMID: 21175228 Review.
Cited by
-
Infliximab-induced autoimmune hepatitis requiring liver transplantation.Clin Case Rep. 2019 Sep 27;7(11):2135-2139. doi: 10.1002/ccr3.2456. eCollection 2019 Nov. Clin Case Rep. 2019. PMID: 31788265 Free PMC article.
-
Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.World J Gastroenterol. 2015 Jun 28;21(24):7584-8. doi: 10.3748/wjg.v21.i24.7584. World J Gastroenterol. 2015. PMID: 26140007 Free PMC article.
-
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.Int J Mol Sci. 2018 Jul 27;19(8):2199. doi: 10.3390/ijms19082199. Int J Mol Sci. 2018. PMID: 30060508 Free PMC article. Review.
-
Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.Hepatol Commun. 2020 Jan 2;4(2):172-184. doi: 10.1002/hep4.1465. eCollection 2020 Feb. Hepatol Commun. 2020. PMID: 32025603 Free PMC article. Review.
-
Three-year outcomes of tumor necrosis factor alpha inhibitor therapy in rheumatoid arthritis patients with elevated liver enzymes.World J Hepatol. 2025 Jul 27;17(7):108051. doi: 10.4254/wjh.v17.i7.108051. World J Hepatol. 2025. PMID: 40747221 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
